Compare · AXSM vs NMRA

AXSM vs NMRA

Side-by-side comparison of Axsome Therapeutics Inc. (AXSM) and Neumora Therapeutics Inc. (NMRA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both companies sit in the Health Care sector. AXSM focuses on Biotechnology: Pharmaceutical Preparations, while NMRA focuses on Biotechnology: Biological Products (No Diagnostic Substances).
  • AXSM is the larger of the two at $7.15B, about 115.5x NMRA ($61.9M).
  • NMRA has been more active in the news (5 items in the past 4 weeks vs 4 for AXSM).
  • AXSM has more recent analyst coverage (25 ratings vs 23 for NMRA).
MetricAXSMNMRA
Company
Axsome Therapeutics Inc.
Neumora Therapeutics Inc.
Price
-
-
Market cap
$7.15B
$61.9M
1M return
-
-
1Y return
-
-
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Exchange
NASDAQ
NASDAQ
IPO
2015
2023
News (4w)
4
5
Recent ratings
25
23
AXSM

Axsome Therapeutics Inc.

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Latest AXSM

Latest NMRA